Global Levodopa Market Research Report 2023

Report ID: 1887523 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
1 Levodopa Market Overview
    1.1 Product Overview and Scope of Levodopa
    1.2 Levodopa Segment by Type
        1.2.1 Global Levodopa Market Size Growth Rate Analysis by Type 2022 VS 2028
        1.2.2 Purity: 98%
        1.2.3 Purity: 99%
    1.3 Levodopa Segment by Application
        1.3.1 Global Levodopa Consumption Comparison by Application: 2022 VS 2028
        1.3.2 Tablet Products
        1.3.3 Capsule Products
        1.3.4 Others
    1.4 Global Market Growth Prospects
        1.4.1 Global Levodopa Revenue Estimates and Forecasts (2017-2028)
        1.4.2 Global Levodopa Production Capacity Estimates and Forecasts (2017-2028)
        1.4.3 Global Levodopa Production Estimates and Forecasts (2017-2028)
    1.5 Global Market Size by Region
        1.5.1 Global Levodopa Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
        1.5.2 North America Levodopa Estimates and Forecasts (2017-2028)
        1.5.3 Europe Levodopa Estimates and Forecasts (2017-2028)
        1.5.4 China Levodopa Estimates and Forecasts (2017-2028)
        1.5.5 Japan Levodopa Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
    2.1 Global Levodopa Production Capacity Market Share by Manufacturers (2017-2022)
    2.2 Global Levodopa Revenue Market Share by Manufacturers (2017-2022)
    2.3 Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.4 Global Levodopa Average Price by Manufacturers (2017-2022)
    2.5 Manufacturers Levodopa Production Sites, Area Served, Product Types
    2.6 Levodopa Market Competitive Situation and Trends
        2.6.1 Levodopa Market Concentration Rate
        2.6.2 Global 5 and 10 Largest Levodopa Players Market Share by Revenue
        2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
    3.1 Global Production Capacity of Levodopa Market Share by Region (2017-2022)
    3.2 Global Levodopa Revenue Market Share by Region (2017-2022)
    3.3 Global Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.4 North America Levodopa Production
        3.4.1 North America Levodopa Production Growth Rate (2017-2022)
        3.4.2 North America Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.5 Europe Levodopa Production
        3.5.1 Europe Levodopa Production Growth Rate (2017-2022)
        3.5.2 Europe Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.6 China Levodopa Production
        3.6.1 China Levodopa Production Growth Rate (2017-2022)
        3.6.2 China Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.7 Japan Levodopa Production
        3.7.1 Japan Levodopa Production Growth Rate (2017-2022)
        3.7.2 Japan Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Levodopa Consumption by Region
    4.1 Global Levodopa Consumption by Region
        4.1.1 Global Levodopa Consumption by Region
        4.1.2 Global Levodopa Consumption Market Share by Region
    4.2 North America
        4.2.1 North America Levodopa Consumption by Country
        4.2.2 U.S.
        4.2.3 Canada
    4.3 Europe
        4.3.1 Europe Levodopa Consumption by Country
        4.3.2 Germany
        4.3.3 France
        4.3.4 U.K.
        4.3.5 Italy
        4.3.6 Russia
    4.4 Asia Pacific
        4.4.1 Asia Pacific Levodopa Consumption by Region
        4.4.2 China
        4.4.3 Japan
        4.4.4 South Korea
        4.4.5 China Taiwan
        4.4.6 Southeast Asia
        4.4.7 India
        4.4.8 Australia
    4.5 Latin America
        4.5.1 Latin America Levodopa Consumption by Country
        4.5.2 Mexico
        4.5.3 Brazil
5 Segment by Type
    5.1 Global Levodopa Production Market Share by Type (2017-2022)
    5.2 Global Levodopa Revenue Market Share by Type (2017-2022)
    5.3 Global Levodopa Price by Type (2017-2022)
6 Segment by Application
    6.1 Global Levodopa Production Market Share by Application (2017-2022)
    6.2 Global Levodopa Revenue Market Share by Application (2017-2022)
    6.3 Global Levodopa Price by Application (2017-2022)
7 Key Companies Profiled
    7.1 Shandong Xinhua Pharmaceutical Co
        7.1.1 Shandong Xinhua Pharmaceutical Co Levodopa Corporation Information
        7.1.2 Shandong Xinhua Pharmaceutical Co Levodopa Product Portfolio
        7.1.3 Shandong Xinhua Pharmaceutical Co Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.1.4 Shandong Xinhua Pharmaceutical Co Main Business and Markets Served
        7.1.5 Shandong Xinhua Pharmaceutical Co Recent Developments/Updates
    7.2 Ajinomoto
        7.2.1 Ajinomoto Levodopa Corporation Information
        7.2.2 Ajinomoto Levodopa Product Portfolio
        7.2.3 Ajinomoto Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.2.4 Ajinomoto Main Business and Markets Served
        7.2.5 Ajinomoto Recent Developments/Updates
    7.3 Daiichi Sankyo Chemical Pharma Co
        7.3.1 Daiichi Sankyo Chemical Pharma Co Levodopa Corporation Information
        7.3.2 Daiichi Sankyo Chemical Pharma Co Levodopa Product Portfolio
        7.3.3 Daiichi Sankyo Chemical Pharma Co Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.3.4 Daiichi Sankyo Chemical Pharma Co Main Business and Markets Served
        7.3.5 Daiichi Sankyo Chemical Pharma Co Recent Developments/Updates
    7.4 Delmar Chemicals Inc
        7.4.1 Delmar Chemicals Inc Levodopa Corporation Information
        7.4.2 Delmar Chemicals Inc Levodopa Product Portfolio
        7.4.3 Delmar Chemicals Inc Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.4.4 Delmar Chemicals Inc Main Business and Markets Served
        7.4.5 Delmar Chemicals Inc Recent Developments/Updates
    7.5 Divis Laboratories Ltd
        7.5.1 Divis Laboratories Ltd Levodopa Corporation Information
        7.5.2 Divis Laboratories Ltd Levodopa Product Portfolio
        7.5.3 Divis Laboratories Ltd Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.5.4 Divis Laboratories Ltd Main Business and Markets Served
        7.5.5 Divis Laboratories Ltd Recent Developments/Updates
    7.6 Egis Pharmaceuticals Private Ltd
        7.6.1 Egis Pharmaceuticals Private Ltd Levodopa Corporation Information
        7.6.2 Egis Pharmaceuticals Private Ltd Levodopa Product Portfolio
        7.6.3 Egis Pharmaceuticals Private Ltd Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.6.4 Egis Pharmaceuticals Private Ltd Main Business and Markets Served
        7.6.5 Egis Pharmaceuticals Private Ltd Recent Developments/Updates
    7.7 Hangzhou Longshine Bio-Tech Co
        7.7.1 Hangzhou Longshine Bio-Tech Co Levodopa Corporation Information
        7.7.2 Hangzhou Longshine Bio-Tech Co Levodopa Product Portfolio
        7.7.3 Hangzhou Longshine Bio-Tech Co Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.7.4 Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
        7.7.5 Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
    7.8 Hoffmann La Roche Inc
        7.8.1 Hoffmann La Roche Inc Levodopa Corporation Information
        7.8.2 Hoffmann La Roche Inc Levodopa Product Portfolio
        7.8.3 Hoffmann La Roche Inc Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.8.4 Hoffmann La Roche Inc Main Business and Markets Served
        7.7.5 Hoffmann La Roche Inc Recent Developments/Updates
    7.9 Suzhou Ryway Biotech
        7.9.1 Suzhou Ryway Biotech Levodopa Corporation Information
        7.9.2 Suzhou Ryway Biotech Levodopa Product Portfolio
        7.9.3 Suzhou Ryway Biotech Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.9.4 Suzhou Ryway Biotech Main Business and Markets Served
        7.9.5 Suzhou Ryway Biotech Recent Developments/Updates
    7.10 Teva Pharmaceutical Industries Ltd
        7.10.1 Teva Pharmaceutical Industries Ltd Levodopa Corporation Information
        7.10.2 Teva Pharmaceutical Industries Ltd Levodopa Product Portfolio
        7.10.3 Teva Pharmaceutical Industries Ltd Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.10.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
        7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    7.11 Torrent Pharmaceuticals Limited
        7.11.1 Torrent Pharmaceuticals Limited Levodopa Corporation Information
        7.11.2 Torrent Pharmaceuticals Limited Levodopa Product Portfolio
        7.11.3 Torrent Pharmaceuticals Limited Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.11.4 Torrent Pharmaceuticals Limited Main Business and Markets Served
        7.11.5 Torrent Pharmaceuticals Limited Recent Developments/Updates
    7.12 Zhejiang Huahai Pharmaceutical Co
        7.12.1 Zhejiang Huahai Pharmaceutical Co Levodopa Corporation Information
        7.12.2 Zhejiang Huahai Pharmaceutical Co Levodopa Product Portfolio
        7.12.3 Zhejiang Huahai Pharmaceutical Co Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.12.4 Zhejiang Huahai Pharmaceutical Co Main Business and Markets Served
        7.12.5 Zhejiang Huahai Pharmaceutical Co Recent Developments/Updates
    7.13 Zhejiang Wild Wind Pharmaceutical
        7.13.1 Zhejiang Wild Wind Pharmaceutical Levodopa Corporation Information
        7.13.2 Zhejiang Wild Wind Pharmaceutical Levodopa Product Portfolio
        7.13.3 Zhejiang Wild Wind Pharmaceutical Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.13.4 Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served
        7.13.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
    7.14 Broahony Group
        7.14.1 Broahony Group Levodopa Corporation Information
        7.14.2 Broahony Group Levodopa Product Portfolio
        7.14.3 Broahony Group Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.14.4 Broahony Group Main Business and Markets Served
        7.14.5 Broahony Group Recent Developments/Updates
    7.15 Lanpharma Chemical Co
        7.15.1 Lanpharma Chemical Co Levodopa Corporation Information
        7.15.2 Lanpharma Chemical Co Levodopa Product Portfolio
        7.15.3 Lanpharma Chemical Co Levodopa Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.15.4 Lanpharma Chemical Co Main Business and Markets Served
        7.15.5 Lanpharma Chemical Co Recent Developments/Updates
8 Levodopa Manufacturing Cost Analysis
    8.1 Levodopa Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Levodopa
    8.4 Levodopa Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Levodopa Distributors List
    9.3 Levodopa Customers
10 Market Dynamics
    10.1 Levodopa Industry Trends
    10.2 Levodopa Market Drivers
    10.3 Levodopa Market Challenges
    10.4 Levodopa Market Restraints
11 Production and Supply Forecast
    11.1 Global Forecasted Production of Levodopa by Region (2023-2028)
    11.2 North America Levodopa Production, Revenue Forecast (2023-2028)
    11.3 Europe Levodopa Production, Revenue Forecast (2023-2028)
    11.4 China Levodopa Production, Revenue Forecast (2023-2028)
    11.5 Japan Levodopa Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
    12.1 Global Forecasted Demand Analysis of Levodopa
    12.2 North America Forecasted Consumption of Levodopa by Country
    12.3 Europe Market Forecasted Consumption of Levodopa by Country
    12.4 Asia Pacific Market Forecasted Consumption of Levodopa by Region
    12.5 Latin America Forecasted Consumption of Levodopa by Country
13 Forecast by Type and by Application (2023-2028)
    13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
        13.1.1 Global Forecasted Production of Levodopa by Type (2023-2028)
        13.1.2 Global Forecasted Revenue of Levodopa by Type (2023-2028)
        13.1.3 Global Forecasted Price of Levodopa by Type (2023-2028)
    13.2 Global Forecasted Consumption of Levodopa by Application (2023-2028)
        13.2.1 Global Forecasted Production of Levodopa by Application (2023-2028)
        13.2.2 Global Forecasted Revenue of Levodopa by Application (2023-2028)
        13.2.3 Global Forecasted Price of Levodopa by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
    15.1 Methodology/Research Approach
        15.1.1 Research Programs/Design
        15.1.2 Market Size Estimation
        15.1.3 Market Breakdown and Data Triangulation
    15.2 Data Source
        15.2.1 Secondary Sources
        15.2.2 Primary Sources
    15.3 Author List
    15.4 Disclaimer
List of Tables
    Table 1. Global Levodopa Market Size by Type (MT) & (US$ Million) (2022 VS 2028)
    Table 2. Global Levodopa Market Size by Application (MT) & (US$ Million) (2022 VS 2028)
    Table 3. Levodopa Market Size Comparison by Region: 2017 VS 2021 VS 2028
    Table 4. Global Levodopa Production Capacity by Manufacturers (2017-2022) & (MT)
    Table 5. Global Levodopa Production (MT) by Manufacturers (2017-2022)
    Table 6. Global Levodopa Production Market Share by Manufacturers (2017-2022)
    Table 7. Global Levodopa Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 8. Global Levodopa Revenue Share by Manufacturers (2017-2022)
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Levodopa as of 2021)
    Table 10. Global Market Levodopa Average Price (USD/MT) of Key Manufacturers (2017-2022)
    Table 11. Manufacturers Levodopa Production Sites and Area Served
    Table 12. Manufacturers Levodopa Product Types
    Table 13. Global Levodopa Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Levodopa Production Capacity (MT) by Region (2017-2022)
    Table 16. Global Levodopa Production (MT) by Region (2017-2022)
    Table 17. Global Levodopa Revenue (US$ Million) by Region (2017-2022)
    Table 18. Global Levodopa Revenue Market Share by Region (2017-2022)
    Table 19. Global Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 20. North America Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 21. Europe Levodopa Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 22. China Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 23. Japan Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 24. Global Levodopa Consumption Market by Region (2017-2022) & (MT)
    Table 25. Global Levodopa Consumption Market Share by Region (2017-2022)
    Table 26. North America Levodopa Consumption by Country (2017-2022) & (MT)
    Table 27. Europe Levodopa Consumption by Country (2017-2022) & (MT)
    Table 28. Asia Pacific Levodopa Consumption by Region (2017-2022) & (MT)
    Table 29. Latin America Levodopa Consumption by Country (2017-2022) & (MT)
    Table 30. Global Levodopa Production (MT) by Type (2017-2022)
    Table 31. Global Levodopa Production Market Share by Type (2017-2022)
    Table 32. Global Levodopa Revenue (US$ Million) by Type (2017-2022)
    Table 33. Global Levodopa Revenue Share by Type (2017-2022)
    Table 34. Global Levodopa Price (USD/MT) by Type (2017-2022)
    Table 35. Global Levodopa Production by Application (2017-2022) & (MT)
    Table 36. Global Levodopa Production Market Share by Application (2017-2022)
    Table 37. Global Levodopa Revenue (US$ Million) by Application (2017-2022)
    Table 38. Global Levodopa Revenue Share by Application (2017-2022)
    Table 39. Global Levodopa Price (USD/MT) by Application (2017-2022)
    Table 40. Shandong Xinhua Pharmaceutical Co Levodopa Corporation Information
    Table 41. Shandong Xinhua Pharmaceutical Co Specification and Application
    Table 42. Shandong Xinhua Pharmaceutical Co Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 43. Shandong Xinhua Pharmaceutical Co Main Business and Markets Served
    Table 44. Shandong Xinhua Pharmaceutical Co Recent Developments/Updates
    Table 45. Ajinomoto Levodopa Corporation Information
    Table 46. Ajinomoto Specification and Application
    Table 47. Ajinomoto Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 48. Ajinomoto Main Business and Markets Served
    Table 49. Ajinomoto Recent Developments/Updates
    Table 50. Daiichi Sankyo Chemical Pharma Co Levodopa Corporation Information
    Table 51. Daiichi Sankyo Chemical Pharma Co Specification and Application
    Table 52. Daiichi Sankyo Chemical Pharma Co Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 53. Daiichi Sankyo Chemical Pharma Co Main Business and Markets Served
    Table 54. Daiichi Sankyo Chemical Pharma Co Recent Developments/Updates
    Table 55. Delmar Chemicals Inc Levodopa Corporation Information
    Table 56. Delmar Chemicals Inc Specification and Application
    Table 57. Delmar Chemicals Inc Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 58. Delmar Chemicals Inc Main Business and Markets Served
    Table 59. Delmar Chemicals Inc Recent Developments/Updates
    Table 60. Divis Laboratories Ltd Levodopa Corporation Information
    Table 61. Divis Laboratories Ltd Specification and Application
    Table 62. Divis Laboratories Ltd Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 63. Divis Laboratories Ltd Main Business and Markets Served
    Table 64. Divis Laboratories Ltd Recent Developments/Updates
    Table 65. Egis Pharmaceuticals Private Ltd Levodopa Corporation Information
    Table 66. Egis Pharmaceuticals Private Ltd Specification and Application
    Table 67. Egis Pharmaceuticals Private Ltd Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 68. Egis Pharmaceuticals Private Ltd Main Business and Markets Served
    Table 69. Egis Pharmaceuticals Private Ltd Recent Developments/Updates
    Table 70. Hangzhou Longshine Bio-Tech Co Levodopa Corporation Information
    Table 71. Hangzhou Longshine Bio-Tech Co Specification and Application
    Table 72. Hangzhou Longshine Bio-Tech Co Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 73. Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
    Table 74. Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
    Table 75. Hoffmann La Roche Inc Levodopa Corporation Information
    Table 76. Hoffmann La Roche Inc Specification and Application
    Table 77. Hoffmann La Roche Inc Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 78. Hoffmann La Roche Inc Main Business and Markets Served
    Table 79. Hoffmann La Roche Inc Recent Developments/Updates
    Table 80. Suzhou Ryway Biotech Levodopa Corporation Information
    Table 81. Suzhou Ryway Biotech Specification and Application
    Table 82. Suzhou Ryway Biotech Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 83. Suzhou Ryway Biotech Main Business and Markets Served
    Table 84. Suzhou Ryway Biotech Recent Developments/Updates
    Table 85. Teva Pharmaceutical Industries Ltd Levodopa Corporation Information
    Table 86. Teva Pharmaceutical Industries Ltd Specification and Application
    Table 87. Teva Pharmaceutical Industries Ltd Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 88. Teva Pharmaceutical Industries Ltd Main Business and Markets Served
    Table 89. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 90. Torrent Pharmaceuticals Limited Levodopa Corporation Information
    Table 91. Torrent Pharmaceuticals Limited Specification and Application
    Table 92. Torrent Pharmaceuticals Limited Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 93. Torrent Pharmaceuticals Limited Main Business and Markets Served
    Table 94. Torrent Pharmaceuticals Limited Recent Developments/Updates
    Table 95. Zhejiang Huahai Pharmaceutical Co Levodopa Corporation Information
    Table 96. Zhejiang Huahai Pharmaceutical Co Specification and Application
    Table 97. Zhejiang Huahai Pharmaceutical Co Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 98. Zhejiang Huahai Pharmaceutical Co Main Business and Markets Served
    Table 99. Zhejiang Huahai Pharmaceutical Co Recent Developments/Updates
    Table 100. Zhejiang Wild Wind Pharmaceutical Levodopa Corporation Information
    Table 101. Zhejiang Wild Wind Pharmaceutical Specification and Application
    Table 102. Zhejiang Wild Wind Pharmaceutical Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 103. Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served
    Table 104. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
    Table 105. Broahony Group Levodopa Corporation Information
    Table 106. Broahony Group Specification and Application
    Table 107. Broahony Group Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. Broahony Group Main Business and Markets Served
    Table 109. Broahony Group Recent Developments/Updates
    Table 110. Broahony Group Levodopa Corporation Information
    Table 111. Lanpharma Chemical Co Specification and Application
    Table 112. Lanpharma Chemical Co Levodopa Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Lanpharma Chemical Co Main Business and Markets Served
    Table 114. Lanpharma Chemical Co Recent Developments/Updates
    Table 115. Production Base and Market Concentration Rate of Raw Material
    Table 116. Key Suppliers of Raw Materials
    Table 117. Levodopa Distributors List
    Table 118. Levodopa Customers List
    Table 119. Levodopa Market Trends
    Table 120. Levodopa Market Drivers
    Table 121. Levodopa Market Challenges
    Table 122. Levodopa Market Restraints
    Table 123. Global Levodopa Production (MT) Forecast by Region (2023-2028)
    Table 124. North America Levodopa Consumption Forecast by Country (2023-2028) & (MT)
    Table 125. Europe Levodopa Consumption Forecast by Country (2023-2028) & (MT)
    Table 126. Asia Pacific Levodopa Consumption Forecast by Region (2023-2028) & (MT)
    Table 127. Latin America Levodopa Consumption Forecast by Country (2023-2028) & (MT)
    Table 128. Global Levodopa Production Forecast by Type (2023-2028) & (MT)
    Table 129. Global Levodopa Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 130. Global Levodopa Price Forecast by Type (2023-2028) & (USD/MT)
    Table 131. Global Levodopa Production Forecast by Application (2023-2028) & (MT)
    Table 132. Global Levodopa Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 133. Global Levodopa Price Forecast by Application (2023-2028) & (USD/MT)
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Levodopa
    Figure 2. Global Levodopa Market Share by Type: 2022 VS 2028
    Figure 3. Purity: 98% Product Picture
    Figure 4. Purity: 99% Product Picture
    Figure 5. Global Levodopa Market Share by Application: 2022 VS 2028
    Figure 6. Tablet Products
    Figure 7. Capsule Products
    Figure 8. Others
    Figure 9. Global Levodopa Revenue (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Levodopa Revenue (US$ Million) (2017-2028)
    Figure 11. Global Levodopa Production Capacity (MT) & (2017-2028)
    Figure 12. Global Levodopa Production (MT) & (2017-2028)
    Figure 13. North America Levodopa Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 14. Europe Levodopa Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 15. China Levodopa Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 16. Japan Levodopa Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 17. Levodopa Production Share by Manufacturers in 2021
    Figure 18. Global Levodopa Revenue Share by Manufacturers in 2021
    Figure 19. Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Market Levodopa Average Price (USD/MT) of Key Manufacturers in 2021
    Figure 21. The Global 5 and 10 Largest Players: Market Share by Levodopa Revenue in 2021
    Figure 22. Global Levodopa Production Market Share by Region (2017-2022)
    Figure 23. North America Levodopa Production (MT) Growth Rate (2017-2022)
    Figure 24. Europe Levodopa Production (MT) Growth Rate (2017-2022)
    Figure 25. China Levodopa Production (MT) Growth Rate (2017-2022)
    Figure 26. Japan Levodopa Production (MT) Growth Rate (2017-2022)
    Figure 27. Global Levodopa Consumption Market Share by Region (2017-2022)
    Figure 28. North America Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 29. North America Levodopa Consumption Market Share by Country in 2021
    Figure 30. Canada Levodopa Consumption Growth Rate (2017-2022) & (MT)
    Figure 31. U.S. Levodopa Consumption Growth Rate (2017-2022) & (MT)
    Figure 32. Europe Levodopa Consumption Growth Rate (2017-2022) & (MT)
    Figure 33. Europe Levodopa Consumption Market Share by Country in 2021
    Figure 34. Germany Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 35. France Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 36. U.K. Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 37. Italy Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 38. Russia Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 39. Asia Pacific Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 40. Asia Pacific Levodopa Consumption Market Share by Regions in 2021
    Figure 41. China Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 42. Japan Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 43. South Korea Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 44. China Taiwan Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 45. Southeast Asia Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 46. India Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 47. Australia Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 48. Latin America Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 49. Latin America Levodopa Consumption Market Share by Country in 2021
    Figure 50. Mexico Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 51. Brazil Levodopa Consumption and Growth Rate (2017-2022) & (MT)
    Figure 52. Production Market Share of Levodopa by Type (2017-2022)
    Figure 53. Production Market Share of Levodopa by Type in 2021
    Figure 54. Revenue Share of Levodopa by Type (2017-2022)
    Figure 55. Revenue Market Share of Levodopa by Type in 2021
    Figure 56. Production Market Share of Levodopa by Application (2017-2022)
    Figure 57. Production Market Share of Levodopa by Application in 2021
    Figure 58. Revenue Share of Levodopa by Application (2017-2022)
    Figure 59. Revenue Market Share of Levodopa by Application in 2021
    Figure 60. Manufacturing Cost Structure of Levodopa
    Figure 61. Manufacturing Process Analysis of Levodopa
    Figure 62. Levodopa Industrial Chain Analysis
    Figure 63. Channels of Distribution
    Figure 64. Distributors Profiles
    Figure 65. Global Levodopa Production Market Share Forecast by Region (2023-2028)
    Figure 66. North America Levodopa Production (MT) Growth Rate Forecast (2023-2028)
    Figure 67. Europe Levodopa Production (MT) Growth Rate Forecast (2023-2028)
    Figure 68. China Levodopa Production (MT) Growth Rate Forecast (2023-2028)
    Figure 69. Japan Levodopa Production (MT) Growth Rate Forecast (2023-2028)
    Figure 70. Global Forecasted Demand Analysis of Levodopa (2017-2028) & (MT)
    Figure 71. Global Levodopa Production Market Share Forecast by Type (2023-2028)
    Figure 72. Global Levodopa Revenue Market Share Forecast by Type (2023-2028)
    Figure 73. Global Levodopa Production Market Share Forecast by Application (2023-2028)
    Figure 74. Global Levodopa Revenue Market Share Forecast by Application (2023-2028)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shandong Xinhua Pharmaceutical Co
Ajinomoto
Daiichi Sankyo Chemical Pharma Co
Delmar Chemicals Inc
Divis Laboratories Ltd
Egis Pharmaceuticals Private Ltd
Hangzhou Longshine Bio-Tech Co
Hoffmann La Roche Inc
Suzhou Ryway Biotech
Teva Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical Co
Zhejiang Wild Wind Pharmaceutical
Broahony Group
Lanpharma Chemical Co
Frequently Asked Questions
Levodopa report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Levodopa report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Levodopa report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

L-Isoleucine

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

L-Glutamic Acid

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Biomass Recycling

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More